Amprion Newsroom
Recent media coverage and announcements.
Press Release
PR Web
SYNTap Biomarker Test helps doctors distinguish Parkinson's Disease from Parkinsonism in early stages
April 6, 2022
Read MorePress Release
PR Newswire
New Paper Published in Alzheimer's: Dementia: The Journal of the Alzheimer's Association Demonstrates Correlation Between the Presence of Misfolded α-Synuclein and Clinical Presentations of Alzheimer's Disease
February 9, 2024
Read MorePress Release
PR Web
New Insights On Alzheimer's And What It Means For Personalized Medicine
January 19, 2022
Read MorePress Release
PR Newswire
Amprion's αSynuclein Seed Amplification Assay to be Showcased at Alzheimer's Association International Conference® 2023 (AAIC®)
July 15, 2023
Read MorePress Release
Business Wire
FDA Issues Letter of Support for α-Synuclein Seed Amplification Assay – The Core Technology Used in Amprion's First Commercial Test
September 5, 2024
Read MorePress Release
PR Newswire
Michael J. Fox Foundation Funds Projects to Speed Development of Quantitative Biomarkers for Parkinson's Disease
May 30, 2024
Read MorePress Release
Business Wire
Amprion Unveils Next-Generation SAAmplify™ Biomarker Panels to Aid in Diagnosis of Neurodegenerative Disorders at AAIC 2024
July 26, 2024
Read MorePress Release
PR Newswire
Amprion Showcases SYNTap® Biomarker Test at AD/PD™ 2023 International Conference
March 27, 2023
Read MorePress Release
PR Newswire
Amprion Joins the Fight Against Parkinson's Through Early Detection Testing
May 23, 2019
Read MorePress Release
PR Web
Amprion Exhibits at MDS International Congress of Parkinson's Disease and Movement Disorders in Madrid and Presents Scientific Insights On SYNTap® Test at Prion2022 Conference
September 15, 2022
Read MorePress Release
PR Web
Amprion Clinical Laboratory Receives Accreditation from College of American Pathologists
October 27, 2021
Read MorePress Release
PR Web
Amprion Awarded NIH Grant For Analytical Validation of SYNTap® Biomarker Test For Neurological Disease
May 10, 2022
Read MorePress Release
PR Web
Amprion announces SYNTap™ Biomarker Test for early detection of Parkinson's Disease (PD) Lewy Body Dementia (LBD) and Alzheimer's Disease (AD)
October 6, 2021
Read MorePress Release
PR Newswire
Amprion Announces Presentation of Findings Related to Usage of the αSynuclein Seed Amplification Assay in Recent Parkinson's Study at 2023 AAN Annual Meeting
April 21, 2023
Read MorePress Release
PR Newswire
Amprion Announces Granting of European Patents for Seed Amplification Assay Platform
August 15, 2023
Read More
Get in the Know
Bring biological certainty to your diagnosis with Amprion's SAAmplify-É‘SYN test. Order your shipping kits today and help move your patient beyond a probable diagnosis.
